drugset / Trial / NCT03448081
Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene
RandomizedParallel-groupDouble-blindTreatment
Summary
A Phase 2 study evaluating safety, tolerability, and efficacy of SNA-120 ointment when administered topically with calcipotriene ointment for the treatment of pruritus and psoriasis.
Timeline
- Start
- 2018-02-12
- Primary completion
- 2018-11-21
- Completion
- 2018-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CT327 | Unknown | 0.5 % | Topical |
| Comparator | Calcipotriol | Small molecule | 0.005 % | — |